Greetings,
Please join us again welcoming returning company Lexaria Bioscience, Corp. (NASDAQ: LEXX). The company will be providing an update on Thursday, March 24th at 4:30 pm EST. It's been 8 months since they last presented to our investment community. Please take this opportunity to re-connect with the company.
Please join us
For this exclusive corporate presentation, followed by a Q & A session moderated by Bear Creek Capital, featuring questions taken from the audience.
**Must register to receive a webinar link
This Zoom Webinar is an invitation only event and is reserved for accredited investors. The presentation will include an overview of the company's story with recent highlights, followed by a question and answer forum.
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp.'s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 24 patents granted and over 50 patents pending worldwide.
Share Price: $3.04
Market Cap: 18.389 M
Avg. Volume: 78,275
Source: Yahoo Finance
LIVE WEBINAR ON March 24th at 4:30 PM EST
Get up, close and personal with Lexaria Bioscience's Chairman and CEO, Christopher Bunka. Learn about their technologies and the outlook of where the company is going.
Please register to Attend Event
Please register to attend. We look forward to meeting you.
Regards,
Raymond Oliver, CEO
Bear Creek Capital
Bringing companies to you up close and personal. Access upper management thru our events while networking with other investors.
If you are looking to gain access to top notch companies working diligently and strategically for their shareholders, these meetings are a great opportunity to access the management team without going thru hurdles such as gate keepers.
